文献
J-GLOBAL ID:201802255767933553
整理番号:18A1802785
HEK293細胞を過剰発現しているSULT1A3におけるリキリチゲニンの硫酸化動態: リキリチゲニンの硫酸流出における乳癌耐性蛋白質(BCRP)と多剤耐性関連蛋白質4(MRP4)の役割【JST・京大機械翻訳】
Sulfation disposition of liquiritigenin in SULT1A3 overexpressing HEK293 cells: The role of breast cancer resistance protein (BCRP) and multidrug resistance-associated protein 4 (MRP4) in sulfate efflux of liquiritigenin
著者 (8件):
Liu Tong
(Institute for Innovative Drug Design and Evaluation, School of Pharmacy, Henan University, N. Jinming Ave., Kaifeng, Henan 475004, China)
,
Zhang Xiaojing
(Institute for Innovative Drug Design and Evaluation, School of Pharmacy, Henan University, N. Jinming Ave., Kaifeng, Henan 475004, China)
,
Zhang Yidan
(Institute for Innovative Drug Design and Evaluation, School of Pharmacy, Henan University, N. Jinming Ave., Kaifeng, Henan 475004, China)
,
Hou Jiuzhou
(Institute for Innovative Drug Design and Evaluation, School of Pharmacy, Henan University, N. Jinming Ave., Kaifeng, Henan 475004, China)
,
Fang Dong
(Institute for Innovative Drug Design and Evaluation, School of Pharmacy, Henan University, N. Jinming Ave., Kaifeng, Henan 475004, China)
,
Sun Hua
(Institute for Innovative Drug Design and Evaluation, School of Pharmacy, Henan University, N. Jinming Ave., Kaifeng, Henan 475004, China)
,
Li Qin
(Institute for Innovative Drug Design and Evaluation, School of Pharmacy, Henan University, N. Jinming Ave., Kaifeng, Henan 475004, China)
,
Xie Songqiang
(Institute of Chemical Biology, School of Pharmacy, Henan University, N. Jinming Ave., Kaifeng, Henan 475004, China)
資料名:
European Journal of Pharmaceutical Sciences
(European Journal of Pharmaceutical Sciences)
巻:
124
ページ:
228-239
発行年:
2018年
JST資料番号:
W0673A
ISSN:
0928-0987
CODEN:
EPSCED
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)